124 related articles for article (PubMed ID: 3789526)
1. Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.
Revak SD; Merritt TA; Hallman M; Cochrane CG
Am Rev Respir Dis; 1986 Dec; 134(6):1258-65. PubMed ID: 3789526
[TBL] [Abstract][Full Text] [Related]
2. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
[TBL] [Abstract][Full Text] [Related]
3. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
[TBL] [Abstract][Full Text] [Related]
4. The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.
Suzuki Y; Curstedt T; Grossmann G; Kobayashi T; Nilsson R; Nohara K; Robertson B
Eur J Respir Dis; 1986 Nov; 69(5):336-45. PubMed ID: 3792469
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional aspects of protein: phospholipid interactions in surfactant.
Benson BJ; Hawgood S
Eur J Respir Dis Suppl; 1985; 142():29-36. PubMed ID: 3860394
[TBL] [Abstract][Full Text] [Related]
6. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
Notter RH; Shapiro DL; Ohning B; Whitsett JA
Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.
Yu SH; Possmayer F
Biochem J; 1986 May; 236(1):85-9. PubMed ID: 3098235
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
[TBL] [Abstract][Full Text] [Related]
9. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis.
Lesur O; Veldhuizen RA; Whitsett JA; Hull WM; Possmayer F; Cantin A; Bégin R
Lung; 1993; 171(2):63-74. PubMed ID: 8426464
[TBL] [Abstract][Full Text] [Related]
10. Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids.
Berggren P; Curstedt T; Grossman G; Nilsson R; Robertson B
Exp Lung Res; 1985; 8(1):29-51. PubMed ID: 3846531
[TBL] [Abstract][Full Text] [Related]
11. Appearance of paoproteins of pulmonary surfactant in human amniotic fluid.
King RJ; Ruch J; Gikas EG; Platzker AC; Creasy RK
J Appl Physiol; 1975 Nov; 39(5):735-41. PubMed ID: 1242387
[TBL] [Abstract][Full Text] [Related]
12. A new method for measurement of surfactant specific apoprotein in amniotic fluid.
Kashiwabara Y; Onoyama Y; Shimokawa H; Hisanaga S; Nakano H
Int J Gynaecol Obstet; 1989 Jun; 29(2):147-52. PubMed ID: 2568290
[TBL] [Abstract][Full Text] [Related]
13. [Assessment of fetal lung maturity by immunological measurement of fetal pulmonary surfactant apoproteins in amniotic fluid (author's transl)].
Hirano H
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):889-98. PubMed ID: 6809865
[TBL] [Abstract][Full Text] [Related]
14. Surfactant apoprotein A modifies the inhibitory effect of plasma proteins on surfactant activity in vivo.
Yukitake K; Brown CL; Schlueter MA; Clements JA; Hawgood S
Pediatr Res; 1995 Jan; 37(1):21-5. PubMed ID: 7700729
[TBL] [Abstract][Full Text] [Related]
15. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.
Curstedt T; Jörnvall H; Robertson B; Bergman T; Berggren P
Eur J Biochem; 1987 Oct; 168(2):255-62. PubMed ID: 3665923
[TBL] [Abstract][Full Text] [Related]
16. Local effect of lung contusion on lung surfactant composition in multiple trauma patients.
Aufmkolk M; Fischer R; Voggenreiter G; Kleinschmidt C; Schmit-Neuerburg KP; Obertacke U
Crit Care Med; 1999 Aug; 27(8):1441-6. PubMed ID: 10470747
[TBL] [Abstract][Full Text] [Related]
17. Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant.
Robertson B; Curstedt T; Grossmann G; Kobayashi T; Kokubo M; Suzuki Y
Eur J Pediatr; 1988 Feb; 147(2):168-73. PubMed ID: 3366134
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells.
Kuroki Y; Mason RJ; Voelker DR
J Biol Chem; 1988 Mar; 263(7):3388-94. PubMed ID: 2449439
[TBL] [Abstract][Full Text] [Related]
19. Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog.
Liau DF; Barrett CR; Bell AL; Ryan SF
Am Rev Respir Dis; 1987 Aug; 136(2):395-401. PubMed ID: 3619199
[TBL] [Abstract][Full Text] [Related]
20. Effect of reconstituted pulmonary surfactant containing the 6000-dalton hydrophobic protein on lung compliance of prematurely delivered rabbit fetuses.
Yu SH; Wallace D; Bhavnani B; Enhorning G; Harding PG; Possmayer F
Pediatr Res; 1988 Jan; 23(1):23-30. PubMed ID: 3340440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
